The ‘Groeifonds’ proposal NXTGEN HIGHTECH is selected to be worked out in detail to be submitted in October 2021. The Netherlands is an international leader when it comes to ultra-precision high-tech equipment and aims to exploit this expertise in NXTGEN HIGHTECH for production of Organs-on-Chips, among others. In total, 28 projects were selected from 244 initial submissions.

The ‘Topsector HTSM’ has, in close collaboration with knowledge institutes, governments, industry and other topsectors, initiated this widely supported programme (budget € ~1.5 billion) to develop the next generation High Tech Equipment for these industries. One of the six domains of NXTGEN HIGHTECH is ‘Biomedical Production Technologies’ and is being coordinated by Berend van Meer on behalf of hDMT. This domain aims at large scale production of Labs-on-Chips, Organs-on-Chips, Artificial Organs and Cell Production Equipment, in which industrial standardisation and qualification are indispensable.

In case the project will be funded, hDMT partners will be involved closely in the further elaboration and setup of the next steps. For more information about NXTGEN HIGHTECH see https://www.hollandhightech.nl/nxtgen-hightech and about the National ‘Groeifonds’ see https://www.nationaalgroeifonds.nl/.

Source: hDMT

The program for the international MicroNanoConference 2021 is well underway with speakers from academia and industry. On December 2 and 3, 2021 we look forward to meeting you on location in Utrecht, at the Jaarbeurs.

This year’s main theme is: From science to market – scale-up in nanotech

With these sub sessions, that you will find in the program:

  • Nano4Health & Life Sciences
  • Nano4Agri& Food
  • Scale-up in nanotechnology
  • Miniturization in nanotechnology
  • Manufacturing in nanotechnology
  • Life after PhD

Tickets are now available at an early bird rate and it is now also possible to submit an abstract for either a poster or oral presentation at the conference. Read more about the program, tickets and abstract submission on the iMNC21 website.

For companies who would like to both support the micro- nano community and also showcase their company to this community, sponsor and exhibitor opportunities will be published soon.

Read more: micronanoconference.org

Researchers from Eindhoven University of Technology and Radboudumc have interwoven various bone cells into an ‘organoid’ that can independently make new, hard bone tissue. It’s the most complete 3D model of bone formation to date. The 3D model allows for the study of the key biochemical processes in unprecedented detail and could help in cracking the many mysteries surrounding bone formation. Moreover, the lab-grown bone is particularly suitable for testing and designing new treatments for bone diseases such as osteoporosis or osteogenesis imperfecta.

Imagine using stem cells from your bone marrow to grow a new piece of your bone tissue in the lab, after which medical doctors explore how certain drugs affect your bone tissue. In this way, a tailor-made treatment plan could be made for you, and potentially for everyone. Welcome to the world of personalized medicine.

This vision of drug development is no longer science fiction now that researchers from Eindhoven University of Technology and Radboud university medical center have actually realized the first part: growing a lifelike piece of bone tissue from human stem cells. It is the first organoid of bone, a simplified version of the original bone, and the researchers report about it today in the journal Advanced Functional Materials.

Sandra Hofman

Sandra Hofmann: “We show that we can make lifelike bone exclusively with two cell types.” Image: Vincent van den Hoogen

COHERENT PICTURE

“With this, we present, for the first time, the full picture of early-stage bone formation,” says Sandra Hofmann, associate professor in Bioengineering Bone from TU/e. And this is of great importance, particularly as the process by which bones form is still largely a mystery. Bone is a very complex material in which, on the one hand, countless cells and processes interact and, on the other hand, an ingenious matrix of collagen and mineral is built up to provide material strength. Much is known about the individual components, but a coherent picture has been lacking until now.

Three types of cells play the main role in bone formation: osteoblasts (which build bone tissue), osteoclasts (which take bone away) and osteocytes (which regulate the building and breaking down of bone). “Most studies so far have focused on one of these types of cells, but that is not a good representation of the real tissue,” says Hofmann. “We present here a piece of woven bone (early-stage bone) that developed from stem cells and contains two types of bone cells: osteoblasts and osteocytes. We now see that we can make lifelike bone exclusively with these two cell types.”

A tiny part of the bone organoid, reconstructed with 3D electron microscopy. The colors indicate different cells connected to form the osteocyte network, embedded in the collagen matrix (cyan).

GETTING WISER FROM MOLECULAR POKING

“And perhaps more importantly, our system behaves just like early-stage bone “, says Anat Akiva, assistant professor Cell Biology at Radboudumc. “We show that both types of cells produce the proteins that the cells need for their functionality, and we show with the greatest detail that the matrix actually is the bone matrix we see in real tissue.”

The fact that a simplified representation of the formation of bone at the molecular level is now possible offers unprecedented possibilities, according to the researchers. “A bone consists of 99% collagen and minerals, but there is also another 1% of proteins that are essential for successful bone formation,” explains professor Nico Sommerdijk from Radboudumc. “So what’s the role of these proteins? How do they support bone formation? Never before have we been able to look at the milestones of this process at a molecular level.”

And with that, they immediately have a great starting point from which to investigate the cause of genetic bone diseases such as ‘brittle bone disease’ and their possible treatments. “Remember that the origin of many diseases is at the molecular level – and so is the treatment,” says Akiva. “In fact, we now have a simple system in a reliable environment where we can poke around and see what happens.”

REFERENCE

Anat Akiva et al., An Organoid for Woven Bone, Advanced Functional Materials (9 March 2021). DOI:10.1002/adfm.202010524

Source: hDMT Technology news

Press Release Rijksoverheid

Six consortia of companies, educational and knowledge institutions and governments will work in the coming years on research aimed at technological innovation with economic potential. Within the Perspective program of the Netherlands Organization for Scientific Research (NWO), they have been awarded a total of 22 million euros from the Ministry of Economic Affairs and Climate (EZK) for innovative research. The 138 companies and social organizations involved also contribute ten million euros from their own resources.

Economic and social impact

The six awarded programs focus on a new generation of optical broadband connections, the recovery of useful substances from industrial waste streams, the development of lighter materials for CO2 reduction in transport, the standardization of the production of pieces of human organ on a chip, the prevention of freshwater shortages due to better purification techniques and the linking of data for smarter electricity networks that help contribute to the energy transition.

Perspectief is a program that challenges scientists to set up new lines of research with economic and social impact in collaboration with the business community and civil society organizations. Perspectief aims to contribute to the creation of economic opportunities within the key enabling technologies and the social themes of the mission-driven innovation policy.

Development of new technologies is crucial

State Secretary Mona Keijzer (Economic Affairs and Climate): “Innovation is the basis for our future jobs and income. That is why it remains necessary to actively fund research and stimulate collaboration between entrepreneurs, education, science and governments. We focus on major social challenges, for example in the field of healthcare and the energy transition. Development of new technologies is crucial here. It is also necessary to have an eye for the future in order to be able to innovate out of the corona crisis and to strengthen the Dutch economy. ”

The composition of the consortia is characteristic of Perspectief: all players who are required to arrive at usable solutions in practice participate. For example, the program aimed at future smart electricity networks involves not only technology companies and technical service providers, but also the three largest Dutch network operators. In the program that aims to solve freshwater shortages, the researchers are collaborating with engineering firms and water companies, as well as with water boards, municipalities and provinces.